Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 8 results:
[ Author(Desc)] Title Type Year
Filters: Author is Charlton, R. A.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
R. A. Charlton, Snowball, J. M., Nightingale, A. L., and Davis, K. J., Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study, J Allergy Clin Immunol Pract, vol. 3, pp. 772-9.e3, 2015.
R. A. Charlton, Cunnington, M. C., de Vries, C. S., and Weil, J. G., Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries, Drug Saf, vol. 31, pp. 39-51, 2008.
R. A. Charlton, Weil, J. G., Cunnington, M. C., and de Vries, C. S., Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD, Drug Saf, vol. 33, pp. 741-50, 2010.
R. A. Charlton, Weil, J. G., Cunnington, M. C., Ray, S., and de Vries, C. S., Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations, Drug Saf, vol. 34, pp. 157-71, 2011.
R. A. Charlton, Hutchison, A., Davis, K. J., and de Vries, C. S., Asthma management in pregnancy, PLoS One, vol. 8, p. e60247, 2013.
R. A. Charlton, Snowball, J. M., Bloomfield, K., and de Vries, C. S., Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK, PLoS One, vol. 8, p. e83203, 2013.
R. A. Charlton, Pierini, A., Klungsoyr, K., Neville, A. J., Jordan, S., van den Berg, L. T. de Jong, Thayer, D., Bos, H. J., Puccini, A., Hansen, A. V., Gini, R., Engeland, A., Andersen, A. M. Nybo, Dolk, H., and Garne, E., Asthma medication prescribing before, during and after pregnancy: a study in seven European regions, BMJ Open, vol. 6, p. e009237, 2016.
R. A. Charlton, McGrogan, A., Snowball, J., Yates, L. M., Wood, A., Clayton-Smith, J., Smithson, W. H., Richardson, J. L., McHugh, N., Thomas, S. H., Baker, G. A., and Bromley, R., Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort, Drug Saf, vol. 40, pp. 387-397, 2017.
[Page last reviewed 4 May 2021]